Educational Grant Sponsors
AstraZeneca
At AstraZeneca, our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer. To accomplish this, we focus on research and development and our commercial capabilities to deliver a new generation of medicines that have the potential to redefine cancer treatment.
Bristol-Myers Squibb
Bristol-Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol-Myers Squibb company and Juno Therapeutics, a Bristol-Myers Squibb company.
MSD
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
Gold Sponsor
GSK
GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit:
Silver Sponsor
Daiichi Sankyo, Inc.
With a legacy of more than 100 years of scientific expertise and its corporate origin in Japan, Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets.
- www.daiichisankyo.com
- Booth No: 9
Bronze Sponsors
Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.
Pierre Fabre Laboratories
Pierre Fabre is a global player in pharmaceuticals and dermo-cosmetics, with revenues of 2,3 billion euros in 2018 and over 11,000 employees worldwide. In 2018, Pierre Fabre dedicated 187 million euros to R&D in 4 therapeutic areas: oncology, dermatology, dermo-cosmetics and dermo-cosmetics. Its brand Eau thermal Avène is the leading dermo-cosmetic brand in the world. A unique case in France, the company is majority-owned by the Pierre Fabre Foundation, a government-recognized public-interest organization.
Supporter
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. is a leader in innovative drug discovery and development, committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies and has a number of products being developed in collaboration with leading pharmaceutical companies. Astex is a member of the Otsuka group of companies, which also includes Taiho Pharmaceutical and Taiho Oncology.
Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we’re creating a future where disease is a thing of the past. We’re working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Startup contributor
Celgene a Bristol-Myers Squibb Company
Bristol-Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol-Myers Squibb company and Juno Therapeutics, a Bristol-Myers Squibb company.
Publisher
Wisepress Medical Bookshop
Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.
- www.wisepress.com
- Booth No: 2
Exhibitors
IntegraGen
IntegraGen’s mission is to translate molecular data into actionable information by providing cutting-edge genomic services and bioinformatic tools to clinicians, researchers and life sciences companies.
- www.integragen-genomics.com
- Booth No: 6
Oncology Knowledge into Practice
Free, flexible, and interactive continuing medical education (CME) for oncology professionals. Developed in collaboration with expert faculty, all content is localised for practice in specific countries and tailored to suit a variety of learning styles. With accredited content for individual or small group learning, our education is designed to fit in around the learner’s schedule and preferences.
- www.oncologyknowledgeintopractice.com
- Booth No: 4
TFS International AB
TFS was founded in 1996 and has grown to become the leading global mid-size clinical CRO focusing on small and mid-size life science customers. TFS employs more than 700 professionals throughout 21 countries and currently delivers clinical research services in more than 40 countries. We can provide end-to-end solutions or flexible single services. Our partnering approach with customers is based on our four business principles – commitment, flexibility, value creation and global reach. Our core therapeutic specialties are Oncology, Immunology, Dermatology, Ophthalmology, CNS, Cardiology and Endocrinology.
- www.tfscro.com
- Booth No: 8